Active Biotech seeking SEK150M financing

Active Biotech (SSE:ACTI) plans to raise SEK150 million ($20.2 million) in a rights issue through the sale of convertible debentures. The debentures bear 2% annual interest and convert into ACTI shares at SEK40, a 5% premium over ACTI's Tuesday close of SEK38. MGA Holding will act as underwriter. ...